NCT00425711View on ClinicalTrials.gov

Study of Acamprosate in Driving Under the Influence (DUI) Court Participants

NATerminatedINTERVENTIONAL

Enrollment

4

Participants

Timeline

Start Date

February 28, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions

Alcohol Dependence

Interventions

DRUG

Acamprosate

Acamprosate 666 mg tid, or 333 tid in renal impairment, for 12 weeks

Trial Locations (1)

74135

The University of Oklahoma, Tulsa, Tulsa

Sponsors

Collaborators (1)

Forest Laboratories

All Listed Sponsors

collaborator

Forest Laboratories

INDUSTRY

lead

University of Oklahoma

OTHER